New pill could cure parasitic skin disease in months
⭐️ CURE ⭐️
Not yet recruiting
This study tests two doses of an experimental oral drug, LXE408, against a standard treatment (miltefosine) for localized cutaneous leishmaniasis, a parasitic skin disease. About 250 adults in the Americas will take the medicine for several weeks. The main goal is to see if the s…
Phase: PHASE2 • Sponsor: Drugs for Neglected Diseases • Aim: ⭐️ CURE ⭐️
Last updated Jun 27, 2026 12:29 UTC